BCRX - BIOCRYST PHARMACEUTICALS INC
IEX Last Trade
7.71
-0.005 -0.065%
Share volume: 30,171
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$7.72
0.00
-0.06%
Summary score
37%
Profitability
47%
Dept financing
26%
Liquidity
70%
Performance
22%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
30.6%
Return on assets
-10.2%
Return on sales
-195.42%
Return on invested capital
67.02%
Total debt ratio
141.58%
Debt ratio change over timeo
1.57%
Current Ratio
4.08%
Quick Ratio
3.89%
Cash Position Ratio
3.4%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
12.29%
Return on assets
-4.38%
Return on sales
-25.04%
Return on invested capital
58.96%
Total debt ratio
185.46%
Debt ratio change over timeo
2.67%
Current Ratio
4.51%
Quick Ratio
4.25%
Cash Position Ratio
3.54%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
7.43%
Return on assets
-3.1%
Return on sales
-15.62%
Return on invested capital
35.69%
Total debt ratio
201.77%
Debt ratio change over time
3.22%
Current Ratio
3.73%
Quick Ratio
3.48%
Cash Position Ratio
2.81%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-58.86%
Return on assets
-120.05%
Return on sales
-464.43%
Return on invested capital
0.74%
Total debt ratio
157.03%
Debt ratio change over time
1.57%
Current Ratio
6.09%
Quick Ratio
5.78%
Cash Position Ratio
4.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 30.6% | 13.79% | 34.47% | 7.43% |
| Return on assets | -10.2% | 2.76% | 3.15% | 5.62% |
| Return on sales | -195.42% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 67.02% | 2.36% | 5.39% | 19.77% |
| Profitability | 47% | 41% | 61% | 63% |
| Total debt ratio | 141.58% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 1.57% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 41% | 16% | 5% |
| Current Ratio | 4.51% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.25% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.54% | 0.36% | 1.28% | 2.93% |
| Liquididy | 73% | 12% | 28% | 64% |
| Short-term ratios | BCRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 12.29% | 13.77% | 13.25% | 3.8% |
| Return on assets | -4.38% | 2.43% | 1.89% | 3.09% |
| Return on sales | -25.04% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 58.96% | 2.14% | 3.39% | 9.18% |
| Profitability | 47% | 66% | 60% | 61% |
| Total debt ratio | 185.46% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 2.67% | 46.38% | -72.08% | 1.51% |
| Dept financing | 26% | 37% | 13% | 4% |
| Current Ratio | 4.51% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.25% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.54% | 0.36% | 1.28% | 2.93% |
| Liquididy | 69% | 11% | 29% | 71% |